Dr. Sally Arai, MD
Claim this profileStanford University
Studies Myelodysplastic Syndrome
Studies Acute Myelogenous Leukemia
8 reported clinical trials
23 drugs studied
Area of expertise
1Myelodysplastic Syndrome
HLA-A negative
HLA-A positive
HLA positive
2Acute Myelogenous Leukemia
HLA-A negative
HLA-A positive
HLA positive
Affiliated Hospitals
Clinical Trials Sally Arai, MD is currently running
Axicabtagene Ciloleucel
for Non-Hodgkin Lymphoma
This is a phase Ib study to establish safety of Axi-Cel-2 in patients with Large B Cell Lymphoma (LBCL) who are at high risk of relapse.
Recruiting1 award Phase 1
Reduced-Dose Cyclophosphamide
for Leukemia After Stem Cell Transplant
The goal of this clinical trial is to determine the effectiveness of Reduced Dose Post-Transplant Cyclophosphamide (PTCy) in patients with hematologic malignancies after receiving an HLA-Mismatched Unrelated Donor (MMUD) . The main question\[s\] it aims to answer are: * Does a reduced dose of PTCy reduce the occurrence of infections in the first 100 days after transplant? * Does a reduced dose of PTCy maintain the same level of protection against Graft Versus Host Disease (GvHD) as the standard dose of PTCy?
Recruiting1 award Phase 2
More about Sally Arai, MD
Clinical Trial Related4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Sally Arai, MD has experience with
- Cyclophosphamide
- Fludarabine
- Mycophenolate Mofetil
- Tacrolimus
- Total-body Irradiation
- Donor Search Prognosis Score
Breakdown of trials Sally Arai, MD has run
Myelodysplastic Syndrome
Acute Myelogenous Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sally Arai, MD specialize in?
Sally Arai, MD focuses on Myelodysplastic Syndrome and Acute Myelogenous Leukemia. In particular, much of their work with Myelodysplastic Syndrome has involved HLA-A negative patients, or patients who are HLA-A positive.
Is Sally Arai, MD currently recruiting for clinical trials?
Yes, Sally Arai, MD is currently recruiting for 2 clinical trials in Stanford California. If you're interested in participating, you should apply.
Are there any treatments that Sally Arai, MD has studied deeply?
Yes, Sally Arai, MD has studied treatments such as Cyclophosphamide, Fludarabine, Mycophenolate Mofetil.
What is the best way to schedule an appointment with Sally Arai, MD?
Apply for one of the trials that Sally Arai, MD is conducting.
What is the office address of Sally Arai, MD?
The office of Sally Arai, MD is located at: Stanford University, Stanford, California 94305 United States. This is the address for their practice at the Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.